These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2320076)

  • 1. Treatment of Graves' ophthalmopathy.
    Beck RW; DiLoreto DA
    N Engl J Med; 1990 Apr; 322(15):1088-9. PubMed ID: 2320076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe endocrine ophthalmopathy. A review with case reports].
    Barth A; Bosshard C; Bürgi U; Bürgi H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):3-9. PubMed ID: 1899292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
    N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A
    N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 10. Ophthalmopathy after treatment for Graves' hyperthyroidism.
    Nunery WR
    N Engl J Med; 1992 Oct; 327(18):1320-1. PubMed ID: 1406832
    [No Abstract]   [Full Text] [Related]  

  • 11. Ophthalmopathy after treatment for Graves' hyperthyroidism.
    Mendlovic DB; Saeed Zafar M
    N Engl J Med; 1992 Oct; 327(18):1320; author reply 1321. PubMed ID: 1406831
    [No Abstract]   [Full Text] [Related]  

  • 12. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Graves' ophthalmopathy.
    Utiger RD
    N Engl J Med; 1992 Jun; 326(26):1772-3. PubMed ID: 1375705
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Graves' disease.
    Utiger R
    N Engl J Med; 1978 Mar; 298(12):681-2. PubMed ID: 580106
    [No Abstract]   [Full Text] [Related]  

  • 17. The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients.
    Argov S; Duek D
    Curr Surg; 1982; 39(3):158-62. PubMed ID: 7047083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective study of Graves ophthalmopathy in relation to thyroid treatment (author's transl)].
    Franco Casique JJ; Bolanños Gil F; Llamas Esperón G; Maisterrena JA
    Rev Invest Clin; 1981; 33(4):361-4. PubMed ID: 6800010
    [No Abstract]   [Full Text] [Related]  

  • 20. The low occurrence of clinically significant ophthalmopathy after ablative treatment with radioactive iodine for Graves' hyperthyroidism.
    Ureles AL; Cronmiller JR
    J Nucl Med; 1993 Oct; 34(10):1829. PubMed ID: 8410313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.